Aug 11 (Reuters) - Iress Ltd (IRE) :
- RECEIPT OF REVISED NBIO FROM EQT
- REVISED IMPLIED VALUE OF A$15.91 CASH PER SHARE BEFORE FRANKING CREDITS
- AGREED TO GRANT EQT A PERIOD OF EXCLUSIVITY FOR 30 DAYS TO UNDERTAKE ITS DUE DILIGENCE
- SUBJECT TO DUE DILIGENCE BOARD INTENDS TO UNANIMOUSLY RECOMMEND OFFER
- IMPLIED VALUE OF PROPOSAL EQUATES TO AN EQUITY VALUE OF A$3.1BN AND AN ENTERPRISE VALUE OF A$3.2BN
- FY21 INTERIM DIVIDEND WILL BE PAID IRRESPECTIVE OF WHETHER ANY TRANSACTION WITH EQT PROCEEDS
- PROPOSAL SUBJECT TO NO DIVIDENDS OR CAPITAL RETURNS BY IRESS BEFORE COMPLETION OF PROPOSED TRANSACTION OTHER THAN PROPOSED FY21 INTERIM DIVIDEND
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$8.94 |
Change
-0.190(2.08%) |
Mkt cap ! $1.677B | |||
| Open | High | Low | Value | Volume |
| $9.04 | $9.10 | $8.93 | $1.411M | 156.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 2344 | $8.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $8.94 | 908 | 14 |
View Market Depth
| Last trade - 12.41pm 08/09/2025 (20 minute delay) ? |
| IRE (ASX) Chart |